AFLAC INC

Discover how Aflac’s new €500 M sustainability bond and sports‑medicine partnership boost its brand, capital structure, and ESG appeal.

Discover how Aflac’s community focus, digital‑health rebrand, and underwriting strength drive steady growth in a shifting insurance market.

Explore Aflac’s Q2 2026 results: $4.1 bn revenue, $883 m adjusted earnings drop, and how Gen Z’s AI‑health shift threatens long‑term growth.

Discover how Aflac’s diverse supplemental insurance line and strong U.S./Japan presence drive its $65 billion market cap and investor confidence.

Discover how Aflac balances philanthropy, strong 5‑year stock growth, and strict regulatory compliance—setting a new benchmark for responsible insurance.

JPMorgan trims Aflac’s target price to $108 amid steady growth, noting competitive pressure and inflation impacts while highlighting its product innovation and Asia expansion plans.

Explore how Aflac’s new reinsurance deal with Japan Post could boost capital, expand its Japanese market, and impact investor sentiment before Q1 earnings.

Explore Aflac’s recent institutional buying and selling, its stable 52‑week range, and what Q4 earnings could mean for investors.

Explore Aflac’s recent $870k cancer‑care donation and stable stock activity—discover how the insurer’s philanthropy and market trends shape its future.

Aflac Inc. has disclosed a significant cybersecurity breach, which occurred on June 12, 2025, and may have compromised customer data.